Article Listing - CHMP issues positive opinion on palonosetron
CORTICOSTEROIDS AND OPTIC NEURITIS
9 March 1992
Optic neuritis, an acute demyelinating disease of the optic nerve which often occurs in multiple sclerosis patients, can be successfully...
SOMBRE FUTURE FOR GENERALIST DRUG-MAKERS IN FRANCE?
9 March 1992
In contrast to specialist drug firms such as Innothera, which successfully exploit a niche in the drug market, generalist pharmaceutical...
ROCHE CENTER ESTABLISHED IN USA
9 March 1992
A new study center for nervous system injuries at Washington University in St Louis, Missouri, is being set up to...
ROCHE TO PROMOTE GENENTECH'S DNase
9 March 1992
Swiss major Hoffmann-La Roche and Californian biotechnology concern Genentech last week announced four different international R&D agreements using their combined...
US GAO SLAMS FDA REVIEW OF OTCs
9 March 1992
There is less US Food and Drug Administration scrutiny of over-the-counter drug products than of prescription products, says a new...
ORPHAN DRUG BILL FACES VETO
9 March 1992
Sponsors of legislation now in the Senate which would reduce the market monopoly enjoyed by orphan drug makers fear that...
PRODUCT UPDATE FROM INTERNEURON PHARMA
9 March 1992
Massachusetts company Interneuron Pharma has signed an agreement with Purdue University to license exclusive worldwide rights to its putative antiparkinsonism...
HUMAN CARCINOMA ANTIGEN
9 March 1992
Massachusetts-based company Epigen Inc has signed an agreement with investigators at the University of Oslo, Norway, to characterize the HC...
NONABSORBABLE ANTIBIOTICS
9 March 1992
Decontamination of the digestive tract with topical nonabsorbable antibiotics does not improve survival among patients receiving mechanical ventilation in the...
BIOCHEM PHARMA'S JOHN GILLARD
9 March 1992
John Gillard has been appointed as director of therapeutic research at BioChem Pharma Inc of Canada.
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
